Review
Open access
Oct 2026
Cell-based therapies for malignant glioma
Abstract Despite innovative progress, cellular therapies have not produced durable, population-level survival gains in glioblastoma. Across 3 major modalities, engineered effectors such as chimeric antigen receptor T cell (CAR-T) and natural killer (NK) cells, immune-education platforms such as dendritic and whole-cell...
Rachael Mooney, E. A. Abd El-Fattah, G. Ngai et al.
· Stem Cells Translational Med... · 0 citations